Credit Rating

1911 Gold just secured a $31M upsized financing. It's more than capital; it’s a major endorsement of its strategy to revive a dormant gold mine by 2027.

IonQ's Clavis XG Multiplex aims to solve the quantum threat by using existing fiber, a pragmatic move in the high-stakes race to secure future data.

At Automate 2026's first Humanoid Pavilion, Richtech Robotics showcases its DEX robot. Is this the tipping point for human-robot collaboration in industry?

Aker BioMarine's pact with ENGIE isn't just about PR. It's a move to hourly clean energy matching, a strategic play that redefines operational sustainability.

As autonomous AI agents gain power, the risk of disaster grows. A new solution proposes a 'biometric hard gate' to ensure a human is always in control.

First Internet Bancorp's steady dividend seems standard, but it's a signal of digital banking's maturity and a new era of shareholder value.

With DoD Impact Level 5 authorization, Jeppesen ForeFlight moves beyond commercial success to become a key player in secure military digital transformation.

By achieving CMMC Level 2, LexisNexis Special Services isn't just checking a box; it's setting a new standard for securing government data.

Tenable's new platform update uses AI to validate which cyber threats are truly exploitable, promising to end alert fatigue and focus resources on real risk.

A new partnership between IS3WARE and Privacy Horizon signals a pivotal shift in how our most sensitive sectors will defend against digital and regulatory threats.

As AI expands the cyber attack surface, OffSec launches its OSAI certification, betting that human ingenuity, not automation, is the key to defeating AI threats.

As autonomous AI agents reshape industry, a critical trust gap emerges. Digimarc aims to close it by embedding a verifiable 'birth certificate' into AI actions.

A new investment in clean alumina tech is more than a deal; it’s a strategic move to build a Western-controlled critical materials corridor in the Arctic.

Acurx Pharma's new drug, ibezapolstat, offers a novel weapon against deadly infections like C. diff by sparing good bacteria. Is this the breakthrough we need?

The International Carbon Registry is flipping the script on carbon credits by embedding ratings and insurance risk upfront. Is this the move that finally cleans up the market?

A minor probation mistake can lead to prison. While experts offer online advice, a new 'edvertising' model blurs the line between public service and marketing.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

A silent productivity drain is costing businesses dearly. Over half the workforce aged 40-60 is managing elder care, and the financial and career toll is immense.

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

Amid a venture capital slowdown, a Philadelphia model is gaining traction by prioritizing discipline over hype. We explore how this ecosystem is making startups investor-ready.